BLUE LAKE BIOTECHNOLOGY
Blue Lake Biotechnology is a startup company that focuses on developing a human vaccine using a novel viral vector. Its goal is to develop PIV5-based vaccines for human disease with an initial focus on the respiratory syncytial virus, as well as obtain the FDAโs approval for phase I trial. The company is located in Athens, Georgia and was founded in 2019 by Biao He.
BLUE LAKE BIOTECHNOLOGY
Industry:
Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
Athens, Georgia, United States
Country:
United States
Website Url:
http://www.bluelakebiotechnology.com
Total Employee:
1+
Status:
Active
Contact:
+1 706 201 7798
Total Funding:
8.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail COVID-19 Typekit
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.bluelakebiotechnology.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Blue Lake Biotechnology"
Blue Lake Biotechnology - Crunchbase Company โฆ
Blue Lake Biotechnology is a startup company that focuses on developing a human vaccine using a novel viral vector. Its goal is to develop PIV5-based โฆSee details»
Our Team - Blue Lake Biotechnology
Helen has over 25 years of experience in accounting and finance in the healthcare industry. She has previously served as CFO and Controller for Cardiovascular Clinical Sciences, a full โฆSee details»
Blue Lake Biotechnology | LinkedIn
Blue Lake Biotechnology is an intranasal vaccine company enlisting the full force of the immune system to keep people healthy, prevent serious infectious diseases, and save the lives of vulnerable ...See details»
BLUE LAKE BIOTECHNOLOGY, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BLUE LAKE BIOTECHNOLOGY, INC. of Athens, GA. Get the latest business insights from Dun & Bradstreet.See details»
Blue Lake Biotechnology to Be Featured at the Biotechnology โฆ
May 31, 2023 Athens, GA and Los Gatos, CA โ May 31, 2023 - Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to โฆSee details»
Blue Lake Biotechnology - Leadership Team - The Org
The Leadership Team at Blue Lake Biotechnology is responsible for setting the strategic direction of the company, overseeing operational execution, and guiding the development of its โฆSee details»
Blue Lake Biotech - VentureRadar
Website: https://www.bluelakebiotechnology.com/ Develops intranasal vaccines utilizing a proprietary PIV5-based vector, aiming for easy administration, transport, and ...See details»
Blue Lake Biotechnology to Be Featured at the Biotechnology โฆ
May 31, 2023 Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to protect against serious infectious โฆSee details»
Blue Lake Biotechnology - PitchBook
Blue Lake Biotechnology General Information Description. Developer of infectious diseases vaccines designed to deliver vaccines worldwide. The company makes vaccines using a โฆSee details»
Blue Lake Biotechnology - Overview, News & Similar companies
Blue Lake Biotechnology to Be Featured at the Biotechnology Innovation Organization (BIO) International Convention ATHENS, Ga. and LOS GATOS, Calif., May 31, 2023 /PRNewswire/ โฆSee details»
Our Platform - Blue Lake Biotechnology
Our Platform. We are developing intranasal vaccines to protect the public from life-threatening diseases. Intranasal vaccines are expected to generate mucosal immunity, which should โฆSee details»
Blue Lake Biotechnology Presenting at Upcoming BioFuture and โฆ
Sep 27, 2023 Contacts. Carolyn Hawley Evoke Canale [email protected] 619-849-5382 Samuel Wu, Chief Business Officer Blue Lake Biotechnology, Inc. and CyanVac โฆSee details»
Blue Lake Biotechnology, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Blue Lake Biotechnology, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 21 news, and 1 literature, Disease Domain:Infectious Diseases, โฆSee details»
News - Blue Lake Biotechnology
Athens, GA and Los Gatos, CA โ May 31, 2023 - Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to protect โฆSee details»
Blue Lake Biotechnology, Inc. (Blue Lake Biotechnology, Inc.) - ่ฏ โฆ
This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10^6 PFU and 10^7 PFU) of intranasal BLB-201 โฆSee details»
Blue Lake Biotechnology to Be Featured at the Biotechnology โฆ
May 31, 2023 Learn more at https://www.bluelakebiotechnology.com. CONTACTS: Carolyn Hawley Evoke Canale [email protected] 619-849-5382. Samuel Wu, Chief Business Officer โฆSee details»
Blue Lake Biotechnology - BIO International Convention | BIO
Jun 5, 2023 Blue Lake is a clinical stage company developing novel intranasal vaccines based on parainfluenza virus 5 (PIV5). Our vaccines feature (1) easy administration by nasal spray, โฆSee details»
Inside the futuristic biotech startup Cellares thatโs building a cure ...
5 days ago Inside the futuristic biotech startup Cellares thatโs building a cure for cancer with $355 million in fundingSee details»
Blue Lake Biotechnology Doses First Child in Clinical Trial of Novel ...
Jun 29, 2023 Athens, GA and Los Gatos, CA, June 29, 2023 - Blue Lake Biotechnology, Inc., a clinical stage intranasal vaccine company harnessing the full breadth of the immune system to โฆSee details»
Our Pipeline - Blue Lake Biotechnology
COVID-19. Our intranasal COVID vaccine BLB101 (a.k.a. CVXGA) is designed to produce the mucosal immunity needed to reduce transmission of COVID, and should also help address โฆSee details»